Eloxx Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Eloxx Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2023 was 3.14M shares, a 96.4% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 3.14M -83.5M -96.4% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 2.75M -83.9M -96.8% Aug 9, 2023 10-Q 2023-08-11
Q1 2023 2.17M -84.5M -97.5% Mar 27, 2023 10-K 2023-03-31
Q3 2022 86.7M +404K +0.47% Nov 8, 2022 10-Q 2022-11-10
Q2 2022 86.7M +453K +0.53% Aug 10, 2022 10-Q 2022-08-12
Q1 2022 86.7M +46.4M +115% Mar 25, 2022 10-K 2022-03-30
Q3 2021 86.3M +46.1M +115% Nov 3, 2021 10-Q 2021-11-08
Q2 2021 86.2M +46.1M +115% Aug 9, 2021 10-Q 2021-08-16
Q1 2021 40.2M +96.4K +0.24% Mar 8, 2021 10-K 2021-03-12
Q3 2020 40.2M +150K +0.38% Nov 2, 2020 10-Q 2020-11-06
Q2 2020 40.1M +198K +0.5% Aug 3, 2020 10-Q 2020-08-07
Q1 2020 40.1M +4.09M +11.4% Mar 1, 2020 10-K 2020-03-06
Q3 2019 40M +4.88M +13.9% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 39.9M +5.08M +14.6% Aug 1, 2019 10-Q 2019-08-07
Q1 2019 36M +2.6M +7.77% May 3, 2019 10-Q 2019-05-09
Q4 2018 35.9M +8.33M +30.3% Dec 31, 2018 10-K 2019-03-14
Q3 2018 35.1M -16.3M -31.7% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 34.9M Aug 3, 2018 10-Q 2018-08-10
Q1 2018 33.4M +6.51M +24.2% May 7, 2018 10-Q 2018-05-10
Q4 2017 27.5M +6.79M +32.7% Dec 31, 2017 10-K 2018-03-16
Q3 2017 51.4M +30.9M +151% Sep 25, 2017 10-K 2017-10-13
Q1 2017 26.9M +6.5M +31.8% Apr 28, 2017 10-Q 2017-05-22
Q4 2016 20.7M +316K +1.55% Feb 1, 2017 10-Q 2017-02-10
Q3 2016 20.5M +107K +0.52% Sep 30, 2016 10-K 2016-10-13
Q1 2016 20.4M +4.03M +24.6% May 9, 2016 10-Q 2016-05-12
Q4 2015 20.4M +6.55M +47.3% Feb 5, 2016 10-Q 2016-02-16
Q3 2015 20.4M +6.54M +47.3% Sep 15, 2015 10-K 2015-10-09
Q1 2015 16.4M +9.48M +137% May 11, 2015 10-Q 2015-05-14
Q4 2014 13.9M +8.82M +175% Jan 31, 2015 10-Q 2015-02-17
Q3 2014 13.8M -218M -94% Sep 15, 2014 10-K 2014-09-29
Q1 2014 6.91M -188M -96.5% Apr 30, 2014 10-Q 2014-05-09
Q4 2013 5.04M -142M -96.6% Jan 31, 2014 10-Q 2014-02-14
Q3 2013 232M +115M +98.6% Aug 31, 2013 10-K 2013-09-11
Q1 2013 195M +101M +108% May 10, 2013 10-Q 2013-05-15
Q4 2012 147M +58.9M +67% Jan 31, 2013 10-Q 2013-02-14
Q3 2012 117M +36M +44.5% Sep 15, 2012 10-K/A 2012-10-26
Q1 2012 93.7M Apr 30, 2012 10-Q 2012-05-14
Q4 2011 88M Jan 31, 2012 10-Q 2012-02-14
Q3 2011 80.8M Oct 31, 2011 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.